On October 21, 2025, Aveanna Healthcare Holdings Inc. announced the pricing of a secondary offering of 10 million shares of its common stock at a public offering price of $9.00 per share. The offering is set to settle on October 23, 2025, and the selling stockholders—affiliated with J.H. Whitney Equity Partners VII, LLC—will receive all net proceeds from the sale.
The offering is being managed by Jefferies and J.P. Morgan as joint lead book‑running managers, with Barclays, RBC Capital Markets, BMO Capital Markets, BofA Securities, Truist Securities, Deutsche Bank Securities, and PNC Capital Markets serving as book‑running managers. The selling stockholders have granted the underwriters a 30‑day option to purchase up to an additional 1.5 million shares at the same price. The company is not offering any shares and will not receive any proceeds from the transaction.
This secondary offering provides liquidity to the selling shareholders but does not raise capital for Aveanna. While the issuance may dilute existing shareholders, it has no immediate impact on the company’s cash position or operating performance. Investors should monitor the share count and potential dilution effects as the offering settles.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.